首页> 外文期刊>Anesthesiology >Involvement of beta3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
【24h】

Involvement of beta3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.

机译:β3-肾上腺素能受体参与衰老心脏中改变的β-肾上腺素能反应:一氧化氮合酶1衍生的一氧化氮的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In senescent heart, beta-adrenergic response is altered in parallel with beta1- and beta2-adrenoceptor down-regulation. A negative inotropic effect of beta3-adrenoceptor could be involved. In this study, the authors tested the hypothesis that beta3-adrenoceptor plays a role in beta-adrenergic dysfunction in senescent heart. METHODS: beta-Adrenergic responses were investigated in vivo (echocardiography-dobutamine, electron paramagnetic resonance) and in vitro (isolated left ventricular papillary muscle, electron paramagnetic resonance) in young adult (3-month-old) and senescent (24-month-old) rats. Nitric oxide synthase (NOS) immunolabeling (confocal microscopy), nitric oxide production (electron paramagnetic resonance) and beta-adrenoceptor Western blots were performed in vitro. Data are mean percentages of baseline +/- SD. RESULTS: An impaired positive inotropic effect (isoproterenol) was confirmed in senescent hearts in vivo (117 +/- 23 vs. 162 +/- 16%; P < 0.05) and in vitro (127 +/- 10 vs. 179 +/- 15%; P < 0.05). In the young adult group, the positive inotropic effect was not significantly modified by the nonselective NOS inhibitor N-nitro-L-arginine methylester (L-NAME; 183 +/- 19%), the selective NOS1 inhibitor vinyl-L-N-5(1-imino-3-butenyl)-L-ornithine (L-VNIO; 172 +/- 13%), or the selective NOS2 inhibitor 1400W (183 +/- 19%). In the senescent group, in parallel with beta3-adrenoceptor up-regulation and increased nitric oxide production, the positive inotropic effect was partially restored by L-NAME (151 +/- 8%; P < 0.05) and L-VNIO (149 +/- 7%; P < 0.05) but not by 1400W (132 +/- 11%; not significant). The positive inotropic effect induced by dibutyryl-cyclic adenosine monophosphate was decreased in the senescent group with the specific beta3-adrenoceptor agonist BRL 37344 (167 +/- 10 vs. 142 +/- 10%; P < 0.05). NOS1 and NOS2 were significantly up-regulated in the senescent rat. CONCLUSIONS: In senescent cardiomyopathy, beta3-adrenoceptor overexpression plays an important role in the altered beta-adrenergic response via induction of NOS1-nitric oxide.
机译:背景:在衰老的心脏中,β-肾上腺素能反应与β1-和β2-肾上腺素受体下调同时发生改变。 β3肾上腺素受体的负性肌力作用可能涉及。在这项研究中,作者检验了以下假设:β3-肾上腺素受体在衰老心脏中的β-肾上腺素功能障碍中起作用。方法:研究了成人(3个月大)和衰老(24个月)的体内(超声心动图-多巴酚丁胺,电子顺磁共振)和体外(离体左室乳头肌,电子顺磁共振)β-肾上腺素能反应。老)老鼠。在体外进行一氧化氮合酶(NOS)免疫标记(镜检显微镜),一氧化氮生成(电子顺磁共振)和β-肾上腺素受体蛋白质印迹。数据是基线+/- SD的平均百分比。结果:在体内衰老的心脏(117 +/- 23对162 +/- 16%; P <0.05)和体外(127 +/- 10对179 + /)中证实了正性肌力作用减弱(异丙肾上腺素)。 -15%; P <0.05)。在年轻人组中,非选择性NOS抑制剂N-硝基-L-精氨酸甲酯(L-NAME; 183 +/- 19%),选择性NOS1抑制剂乙烯基-LN-5( 1-亚氨基-3-丁烯基)-L-鸟氨酸(L-VNIO; 172 +/- 13%),或选择性NOS2抑制剂1400W(183 +/- 19%)。在衰老组中,与β3-肾上腺素受体上调同时增加一氧化氮的产生,正性肌力作用被L-NAME(151 +/- 8%; P <0.05)和L-VNIO(149 + /-7%; P <0.05),但不超过1400W(132 +/- 11%;不显着)。在特定的β3-肾上腺素受体激动剂BRL 37344的衰老组中,由二丁酰基环一磷酸腺苷诱导的正性肌力作用降低(167 +/- 10对142 +/- 10%; P <0.05)。 NOS1和NOS2在衰老大鼠中明显上调。结论:在衰老性心肌病中,β3肾上腺素受体的过表达在NOS1一氧化氮的诱导改变β肾上腺素能反应中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号